Newsroom

Welcome to the Pavilion newsroom. Here you can find the latest news and media coverage.

Mercer Completes Acquisition of Investment and Alternatives Consulting, and Wealth Management Operations of Pavilion Financial Corporation

December 4, 2018

Deal expected to give consultants and clients access to broader, deeper global research and specialist resources New York, December 4, 2018 — Mercer, a global consulting leader in advancing health, wealth and career, announced that it completed its acquisition of the investment consulting, alternatives consulting and wealth management operations of Pavilion Financial Corporation (“Pavilion”) effective […]

Read more

Mercer to Acquire Investment and Alternatives Consulting, and Wealth Management Operations of Pavilion Financial Corporation

August 14, 2018

Transaction to complement Mercer’s existing investment consulting, alternatives and wealth management offerings August 14, 2018 – Global, New York/London Mercer, a global consulting leader in advancing health, wealth and career, and a wholly owned subsidiary of Marsh & McLennan Companies (NYSE:MMC), has signed a definitive agreement to acquire the investment consulting, alternatives consulting and wealth management […]

Read more

Brexit Steamrolls Fed Model for Stock Bulls as Bond Yields Drop

July 4, 2016

Bloomberg, June 28, 2016 – With Treasury yields approaching 1.40 percent Monday, rising rates seem like the least of anyone’s problems. Still, should yields start to rise with economic growth still sluggish, the Fed’s warning would be relevant to equity owners, according to Alex Bellefleur, head of global macro research and strategy at Pavilion Global […]

Read more

Buy Emerging Market Local Debt, Or Focus On Bad Loans?

June 27, 2016

“…there are reasons investors should be positive on emerging market debt: emerging markets have issued roughly $65 million in euro-denominated bonds so far this year, and Pavilion Global Markets writes that emerging market debt is “set for a record year.”

Read more

Archive →